›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:Oncomine™ Comprehensive Assay v3M
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Thermo Fisher ScientificType:
Laboratory Developed Test
Related tests:
The Oncomine™ Comprehensive Assay v3 contains targeted, multi-biomarker panels that enable simultaneous detection of hundreds of variants across 161 genes relevant to solid tumors. This assay allows concurrent analysis of DNA and RNA to simultaneously detect multiple types of variants, including hotspots, single nucleotide variants (SNVs), insertions and deletions (INDELs), copy number variants (CNVs), and gene fusions, in a single workflow.
Cancer:
Solid Tumor
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), AKT2 (V-akt murine thymoma viral oncogene homolog 2), AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase), AR (Androgen receptor), ARAF (A-Raf Proto-Oncogene)
See More ...
AKT1 (V-akt murine thymoma viral oncogene homolog 1), AKT2 (V-akt murine thymoma viral oncogene homolog 2), AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase), AR (Androgen receptor), ARAF (A-Raf Proto-Oncogene), AXL (AXL Receptor Tyrosine Kinase), BRAF (B-raf proto-oncogene), BTK (Bruton Tyrosine Kinase), CCND1 (Cyclin D1), CDK4 (Cyclin-dependent kinase 4), CDK6 (Cyclin-dependent kinase 6), CHEK2 (Checkpoint kinase 2), CSF1R (Colony stimulating factor 1 receptor), CTNNB1 (Catenin (cadherin-associated protein), beta 1), DDR2 (Discoidin domain receptor 2), EGFR (Epidermal growth factor receptor), ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3), ERBB4 (erb-b2 receptor tyrosine kinase 4), ERCC2 (Excision repair cross-complementation group 2), EZH2 (Enhancer of zeste 2 polycomb repressive complex 2 subunit), FGFR1 (Fibroblast growth factor receptor 1), FGFR2 (Fibroblast growth factor receptor 2), FGFR3 (Fibroblast growth factor receptor 3), FLT3 (Fms-related tyrosine kinase 3), HER-2 (Human epidermal growth factor receptor 2), JAK2 (Janus kinase 2), KRAS (KRAS proto-oncogene GTPase), MET (MET proto-oncogene, receptor tyrosine kinase), NOTCH1 (Notch 1), NRG1 (Neuregulin 1), NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1), NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2), NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3), PTEN (Phosphatase and tensin homolog), RET (Ret Proto-Oncogene), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS), TERT (Telomerase Reverse Transcriptase)
Method:
Next-Generation Sequencing (NGS)
Confirmatory trial(s)
Confirmatory trial(s)
